- Multimedia -

Detect, Correct, and Prevent Medication Errors with Intelligent Infusion Technology

Activity Description The 2006 Institute of Medicine (IOM) report indicated that approximately one medication error occurs per patient per day in hospital care. Many of these errors occur during the medication administration step of the medication use process. Among the improvement strategies to prevent errors, the IOM report noted the use of technology such as smart infusion pumps with well-defined drug libraries as one mechanism to reduce the chances for errors. However, implementation of smart infusion pump technology requires significant time, effort and resources and multidisciplinary involvement.

Learning Objectives

Upon completion of this activity, nurses and pharmacists will be able to:

• Define intelligent infusion technology.
• Describe the main components of an intelligent infusion system.
• Describe the potential benefits of intelligent infusion technology to patient safety.
• Identify the "5 rights" of medication safety.
• Identify the responsibilities of the pharmacist and the nurse in implementing an intelligent infusion system.

Faculty

Seth Brownlee, PharmD
Advocate Lutheran General Hospital
Park Ridge, Illinois

William H. Puckett, MS, MBA, RPh, FASHP
Principal, WHP-Rx Consulting Speaking
Windermere, Florida

Robin L. Keyack, BSc(Pharm)
Virtua Health
Marlton, New Jersey

Sibyl Mayeda-Yau, MSN, RN
Value Analysis Facilitator
University of Chicago Hospitals
Chicago, Illinois

Linda L. Morgan, RN
Erlanger Health System
Chattanooga, Tennessee

Jim Tillery, RPh
Thomas Polonus, IT
Nancy Hedlund, MBA, RPh
Hospira Worldwide, Inc.
Lake Forest, Illinois

CE Accreditation:

Release Date: 03-01-2011
Expiration Date: 03-01-2014

Pharmacists:
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-11-018-H05-P has been assigned to this knowledge-based home-study CE activity (initial release date 03-01-11). This activity is approved for 2.0 contact hours (0.2 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Nurses:
Nurse CE is provided for this activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, Inc. is accredited as a provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 2.0 contact hours of nurse CE credit.

Disclosure Statements

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Ms. Pasell, Heinz/Pasell, Inc., has disclosed serving as a consultant for Hospira, Inc. Ms. McKenna, MGI Communications, has disclosed serving as a consultant for Hospira, Inc. Ms. Hedlund has disclosed that she is an employee of Hospira Worldwide, Inc. Mr. Polonus, Mr. Puckett, and Mr. Tillery have disclosed that they are employees of Hospira, Inc. Dr. Brownlee, Ms. Keyack, Ms. Mayeda-Yau, and Ms. Morgan have no commercial / financial relationships to disclose.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs/devices for unlabeled indications. Use of drugs/devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

Funding

This activity was supported by an unrestricted educational grant from Hospira, Inc.